CollimateHealth Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.96M

  • Investors
  • 5

CollimateHealth General Information

Description

Developer of a clinically scalable microbeam radiation technology designed for cancer treatment. The company's system delivers an array of micrometer-scale beams at substantially higher doses than conventional broad-beam radiation, inducing disruptive cell death that increases antigen presentation to activate immune responses beyond the primary tumor while creating temporary channels that improve therapeutic delivery into tumor tissue, enabling radiation oncology centers to combine radiation with chemotherapy and immunotherapy for improved tumor control with reduced damage to surrounding tissue.

Contact Information

Website
www.collimatehealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lilly-Reich-Straße 8
  • 80807 Munich
  • Germany
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Lilly-Reich-Straße 8
  • 80807 Munich
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CollimateHealth Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 15-Jun-2026 $6.96M Completed Startup
To view CollimateHealth’s complete valuation and funding history, request access »

CollimateHealth Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caesar Ventures Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
Positron Ventures Venture Capital Minority
VP Venture Partners Venture Capital Minority
Xista Science Ventures Venture Capital Minority
To view CollimateHealth’s complete investors history, request access »

Ready to get started?

Request a free trial

CollimateHealth FAQs

  • When was CollimateHealth founded?

    CollimateHealth was founded in 2025.

  • Where is CollimateHealth headquartered?

    CollimateHealth is headquartered in Munich, Germany.

  • What industry is CollimateHealth in?

    CollimateHealth’s primary industry is Therapeutic Devices.

  • Is CollimateHealth a private or public company?

    CollimateHealth is a Private company.

  • What is CollimateHealth’s current revenue?

    The current revenue for CollimateHealth is .

  • How much funding has CollimateHealth raised over time?

    CollimateHealth has raised $6.96M.

  • Who are CollimateHealth’s investors?

    Caesar Ventures, High-Tech Gründerfonds, Positron Ventures, VP Venture Partners, and Xista Science Ventures have invested in CollimateHealth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process